Status:
COMPLETED
Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)
Lead Sponsor:
Kessler Foundation
Collaborating Sponsors:
International Progressive MS Alliance
Conditions:
Multiple Sclerosis, Progressive
Cognition - Other
Eligibility:
All Genders
30-59 years
Phase:
NA
Brief Summary
This study is a double-blind placebo-controlled randomized clinical trial (RCT) to provide Class I evidence in support of or in refute of the efficacy of the modified Story Memory Technique (mSMT) in ...
Detailed Description
There is a clear unmet need in the clinical care of persons with Progressive MS - there are no treatments for memory dysfunction with demonstrated efficacy in persons with progressive disease. This is...
Eligibility Criteria
Inclusion
- between the ages of 30 and 59
- diagnosed with Progressive Multiple Sclerosis
- have visual acuity of better then 20/60 in worse eye
Exclusion
- has a prior stroke or neurological injury/disease (brain tumor, epilepsy, traumatic brain injury).
- has a history of psychiatric illness (for example, bipolar disorder, schizophrenia, or psychosis).
- currently taking medications such as: steroids, benzodiazepines, and neuroleptics. .
- difficulty with vision, eyesight worse then 20/60, or has diminished sight in visual field, double vision, or nystagmus.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 2 2017
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT02301247
Start Date
November 1 2014
End Date
April 2 2017
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kessler Foundation
West Orange, New Jersey, United States, 07052